MSF condemns Novo Nordisk double standard in diabetes care
- November 14, 2024
- Health
- 0 Comments
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
Health-e News
